title: Beta-1-Selective Beta-Blockers and Cognitive Functions in Patients With Coronary Artery Disease: A Cross-Sectional Study.
abstract: The association between current beta-1-selective beta-blocker use and cognitive function was evaluated in 722 patients with coronary artery disease without dementia. Beta-1-selective beta-blocker use was associated with worse incidental learning independently of sociodemographic characteristics, clinical coronary artery disease severity, and depression/anxiety.
authors.affiliation: From the Behavioral Medicine Institute (JBu, JBr, JN, NM, AB, RB), Lithuanian University of Health Sciences, Palanga, Lithuania; the Institute of Physiology and Pharmacology (AN), Lithuanian University of Health Sciences, Kaunas, Lithuania; and the Laboratory of Clinical Research, Institute of Neurosciences, Lithuanian University of Health Sciences, Kaunas, Lithuania (AB).
authors.forename: Julius
authors.initials: J
authors.lastname: Burkauskas
authors.affiliation: From the Behavioral Medicine Institute (JBu, JBr, JN, NM, AB, RB), Lithuanian University of Health Sciences, Palanga, Lithuania; the Institute of Physiology and Pharmacology (AN), Lithuanian University of Health Sciences, Kaunas, Lithuania; and the Laboratory of Clinical Research, Institute of Neurosciences, Lithuanian University of Health Sciences, Kaunas, Lithuania (AB).
authors.forename: Aurelija
authors.initials: A
authors.lastname: Noreikaite
authors.affiliation: From the Behavioral Medicine Institute (JBu, JBr, JN, NM, AB, RB), Lithuanian University of Health Sciences, Palanga, Lithuania; the Institute of Physiology and Pharmacology (AN), Lithuanian University of Health Sciences, Kaunas, Lithuania; and the Laboratory of Clinical Research, Institute of Neurosciences, Lithuanian University of Health Sciences, Kaunas, Lithuania (AB).
authors.forename: Adomas
authors.initials: A
authors.lastname: Bunevicius
authors.affiliation: From the Behavioral Medicine Institute (JBu, JBr, JN, NM, AB, RB), Lithuanian University of Health Sciences, Palanga, Lithuania; the Institute of Physiology and Pharmacology (AN), Lithuanian University of Health Sciences, Kaunas, Lithuania; and the Laboratory of Clinical Research, Institute of Neurosciences, Lithuanian University of Health Sciences, Kaunas, Lithuania (AB).
authors.forename: Julija
authors.initials: J
authors.lastname: Brozaitiene
authors.affiliation: From the Behavioral Medicine Institute (JBu, JBr, JN, NM, AB, RB), Lithuanian University of Health Sciences, Palanga, Lithuania; the Institute of Physiology and Pharmacology (AN), Lithuanian University of Health Sciences, Kaunas, Lithuania; and the Laboratory of Clinical Research, Institute of Neurosciences, Lithuanian University of Health Sciences, Kaunas, Lithuania (AB).
authors.forename: Julius
authors.initials: J
authors.lastname: Neverauskas
authors.affiliation: From the Behavioral Medicine Institute (JBu, JBr, JN, NM, AB, RB), Lithuanian University of Health Sciences, Palanga, Lithuania; the Institute of Physiology and Pharmacology (AN), Lithuanian University of Health Sciences, Kaunas, Lithuania; and the Laboratory of Clinical Research, Institute of Neurosciences, Lithuanian University of Health Sciences, Kaunas, Lithuania (AB).
authors.forename: Narseta
authors.initials: N
authors.lastname: Mickuviene
authors.affiliation: From the Behavioral Medicine Institute (JBu, JBr, JN, NM, AB, RB), Lithuanian University of Health Sciences, Palanga, Lithuania; the Institute of Physiology and Pharmacology (AN), Lithuanian University of Health Sciences, Kaunas, Lithuania; and the Laboratory of Clinical Research, Institute of Neurosciences, Lithuanian University of Health Sciences, Kaunas, Lithuania (AB).
authors.forename: Robertas
authors.initials: R
authors.lastname: Bunevicius
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D000368:Aged; D001007:Anxiety / Q000150:complications / Q000523:psychology; D003071:Cognition / Q000187:drug effects*; D003324:Coronary Artery Disease / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D003430:Cross-Sectional Studies; D003863:Depression / Q000150:complications / Q000523:psychology; D005260:Female; D006801:Humans; D007858:Learning / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests
chemical_list: D000319:Adrenergic beta-Antagonists